Overview
NRC market data
Price History
NRC price chart
Valuation & Profitability
- P/E (TTM)
- 80.45 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $0.52 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.29 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 3.0% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 4.2% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $11.01 – $23.68 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $471.4M · P/B 30.40 · P/S 3.37.
Company News
On Aug 7, Shane Harrison, CFO of NRC Health, Tendered Resignation From The Co.; Resignation Effective As August 28, 2026Benzinga · Aug 11, 2026, 8:59 PM
8-K filing — NRC HEALTH (NRC)SEC EDGAR · Aug 11, 2026, 8:31 PM
Citizens Maintains Market Outperform on NRC Health, Raises Price Target to $26Benzinga · Jul 29, 2026, 2:04 PM
National Research Q2 Adj. EPS $0.31 Beats $0.14 Estimate, Sales $35.392M Beat $34.900M EstimateBenzinga · Jul 28, 2026, 8:04 PM
Citizens Initiates Coverage On NRC Health with Market Outperform Rating, Announces Price Target of $23Benzinga · Jun 22, 2026, 3:15 PM